Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization

Document Type


Publication Date



Purpose. To improve the oral efficacy of the recombinant fusion protein containing granulocyte colonystimulating factor (G-CSF) and transferrin (Tf) by inserting a linker between the two protein domains. Materials and Methods. Oligonucleotides encoding flexible and helix-forming peptides were inserted to the recombinant plasmids. The fusion protein without linker insertion was used for comparison. The G-CSF cell-proliferation and Tf receptor-binding activities of the fusion proteins were tested in NFS-60 cells and Caco-2 cells, respectively, and in vivo myelopoietic assay with both subcutaneous and oral administration was performed in BDF1 mice. Results. All fusion proteins produced from transfected HEK293 cells were positive in Western-blotting assay with anti-G-CSF and anti-Tf antibodies. Among them, the fusion protein with a long helical (H4-2) linker showed the highest activity in NFS-60 cell proliferation assay, with an EC50 about ten-fold lower than that of the non-linker fusion protein. The fusion protein with H4-2 linker also showed a significantly higher myelopoietic effect when administered either subcutaneously or orally in BDF1 mice. Conclusion. The insertion of a linker peptide, such as the helix linker H4-2, between G-CSF and Tf domains in the recombinant fusion protein can improve significantly both in vitro and in vivo myelopoietic activity over the non-linker fusion protein.

Publication Title

Pharmaceutical research





First Page


Last Page



This article was published in Pharmaceutical research, Volume 23, Issue 9, Pages 2116-2121.

The published version is available at http://dx.doi.org/10.1007/s11095-006-9059-5.

Copyright © 2006 Springer.

This document is currently not available here.